Pinnacle Financial Group, Inc.’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$30K Buy
+500
New +$31.5K ﹤0.01% 1175

Other funds holding BMRN

Pinnacle Financial Group, Inc.'s BMRN Position: Q3 2026 in Review

Pinnacle Financial Group, Inc. opened a new position in BioMarin Pharmaceuticals (BMRN) in Q3 2026: 500 shares worth $30K. The stake represents ﹤0.01% of the portfolio and ranks #1175 among its holdings.

567 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

  • Pinnacle Financial Group, Inc. held 500 shares of BioMarin Pharmaceuticals worth $30K as of Q3 2026.
  • BioMarin Pharmaceuticals was a new Pinnacle Financial Group, Inc. position in Q3 2026.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #1175 holding.
  • 567 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.